Cargando…

Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia

OBJECTIVES: To explore clinical and demographic characteristics impacting patient functioning by determining extent of overlap in factors driving change in Personal and Social Performance (PSP) and other clinical outcomes. METHODS: Post‐hoc analysis from a single‐arm trial of paliperidone extended r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vauth, Roland, Carpiniello, Bernardo, Turczyński, Jacek, Ivanov, Mikhail, Cherubin, Pierre, Lahaye, Marjolein, Schreiner, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170566/ https://www.ncbi.nlm.nih.gov/pubmed/33355966 http://dx.doi.org/10.1002/mpr.1855

Ejemplares similares

PM481. Tolerability, safety and treatment response of flexibly-dosed paliperidone palmitate in patients hospitalized for an exacerbation of schizophrenia
por: Schreiner, Andreas, et al.
Publicado: (2016)

Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia
por: Helldin, Lars, et al.
Publicado: (2015)

PM480. Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - A Retrospective Observational Study
por: Schreiner, Andreas, et al.
Publicado: (2016)

PM479. Clinical and Functional Response to Paliperidone Palmitate in Early Schizophrenia – A Retrospective Observational Study in Newly Diagnosed Patients Treated Over a 12-Month Period
por: Schreiner, Andreas, et al.
Publicado: (2016)

Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
por: Emsley, Robin, et al.
Publicado: (2017)

Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
por: Schreiner, Andreas, et al.
Publicado: (2016)

A Flexible-Dose Study of Paliperidone ER in Patients With Nonacute Schizophrenia Previously Treated Unsuccessfully With Oral Olanzapine
por: KOTLER, MOSHE, et al.
Publicado: (2016)

Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
por: Carpiniello, Bernardo, et al.
Publicado: (2016)

Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy
por: Manchia, Mirko, et al.
Publicado: (2020)

The Reciprocal Relationship between Suicidality and Stigma
por: Carpiniello, Bernardo, et al.
Publicado: (2017)

Stigma towards patients with schizophrenia and other mental disorders: Challenges and interventions in Italy
por: Carpiniello, B.
Publicado: (2021)

Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia
por: Hargarter, L, et al.
Publicado: (2016)

Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders
por: Pinna, Federica, et al.
Publicado: (2013)

Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy
por: Pinna, Federica, et al.
Publicado: (2015)

Challenges and Future Prospects of Precision Medicine in Psychiatry
por: Manchia, Mirko, et al.
Publicado: (2020)

Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics
por: Schreiner, A, et al.
Publicado: (2015)

Schizophrenia and “unmet needs”: From diagnosis to care in Italy
por: Galderisi, Silvana, et al.
Publicado: (2020)

Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets
por: Piras, Ignazio S, et al.
Publicado: (2018)

The Mental Health Costs of Armed Conflicts—A Review of Systematic Reviews Conducted on Refugees, Asylum-Seekers and People Living in War Zones
por: Carpiniello, Bernardo
Publicado: (2023)

Gender Differences in Remission and Recovery of Schizophrenic and Schizoaffective Patients: Preliminary Results of a Prospective Cohort Study
por: Carpiniello, Bernardo, et al.
Publicado: (2012)

Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
por: Pinna, Federica, et al.
Publicado: (2015)

Relationship between social and cognitive functions in people with schizophrenia
por: Tominaga, Takeo, et al.
Publicado: (2018)

Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia
por: Andreu-Bernabeu, Álvaro, et al.
Publicado: (2022)

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini, Francesco, et al.
Publicado: (2019)

European Psychiatric Association policy paper on ethical aspects in communication with patients and their families
por: Carpiniello, Bernardo, et al.
Publicado: (2020)

Impact of COVID-19 on the Italian Mental Health System: A Narrative Review
por: Carpiniello, Bernardo, et al.
Publicado: (2022)

Mediating Effect of Hope on the Relationship Between Depression and Recovery in Persons With Schizophrenia
por: Sari, Sri Padma, et al.
Publicado: (2021)

Family functioning and personal growth in Italian caregivers living with a family member affected by schizophrenia: Results of an add-on study of the Italian network for research on psychoses
por: Roncone, Rita, et al.
Publicado: (2023)

Social function in schizophrenia and schizoaffective disorder: Associations with personality, symptoms and neurocognition
por: Lysaker, Paul H, et al.
Publicado: (2004)

Emotion Recognition, Emotion Awareness, Metacognition, and Social Functioning in Persons with Schizophrenia
por: Kolavarambath, Radhika, et al.
Publicado: (2020)

Down-Shifting in the YAM: Ce(3+) + Yb(3+) System for Solar Cells
por: Fetliński, Bartosz, et al.
Publicado: (2021)

Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder
por: O’Reilly, Ken, et al.
Publicado: (2015)

Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice
por: Peuskens, Joseph, et al.
Publicado: (2014)

The relationship of antisocial personality disorder and history of conduct disorder with crime incidence in schizophrenia
por: Maghsoodloo, Safa, et al.
Publicado: (2012)

Personalized medicine for schizophrenia
por: Buckley, Peter F., et al.
Publicado: (2017)

Adiponectin and Metabolic status in persons with Schizophrenia: A six month prospective study
por: Saha, S, et al.
Publicado: (2022)

Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand
por: Suttajit, Sirijit, et al.
Publicado: (2010)

Neural Correlates of Variation in Personal Space and Social Functioning in Schizophrenia and Healthy Individuals
por: Zapetis, Sarah L, et al.
Publicado: (2022)

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
por: Manchia, Mirko, et al.
Publicado: (2021)

What gets in the way of social engagement in schizophrenia?
por: Weittenhiller, Lauren P, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mf92ej0gtiu1afk4ta8ah8ahk7